Actavis blockbuster fails to halt US corporate surge
The US investment grade corporate feeding frenzy intensified this week as buyers snapped up more than $20bn of paper in addition to Actavis’s blockbusting $21bn deal.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: